Stage 0 Gastric Cancer
Standard treatment options:
- Surgery.
Stage 0 is gastric cancer confined to mucosa. Experience in Japan, where stage 0 is diagnosed frequently, indicates that more than 90% of patients treated by gastrectomy with lymphadenectomy will survive beyond 5 years. An American series has confirmed these results.[1]
Multiple Endocrine Neoplasia Type 2 (MEN 2)
Clinical Description The endocrine disorders observed in Multiple Endocrine Neoplasia type 2 (MEN 2) are medullary thyroid cancer (MTC), its precursor C-cell hyperplasia (CCH), pheochromocytoma, and parathyroid adenomas and/or hyperplasia. MEN 2-associated MTC is often bilateral and/or multifocal and arises in the background of CCH. In contrast, sporadic MTC is typically unilateral and/or unifocal. Since approximately 75% to 80% of sporadic cases also have associated CCH, this histopathologic...
Read the Multiple Endocrine Neoplasia Type 2 (MEN 2) article > >
Current Clinical Trials
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage 0 gastric cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References:
WebMD Public Information from the National Cancer Institute
